Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/214828
Two genome-wide interaction loci modify the association of nonsteroidal anti-inflammatory drugs with colorectal cancer
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Regular, long-term aspirin use may act synergistically with genetic variants, particularly those in mechanistically relevant pathways, to confer a protective effect on colorectal cancer (CRC) risk. We leveraged pooled data from 52 clinical trial, cohort, and case-control studies that included 30,806 CRC cases and 41,861 controls of European ancestry to conduct a genome-wide interaction scan between regular aspirin/nonsteroidal anti-inflammatory drug (NSAID) use and imputed genetic variants. After adjusting for multiple comparisons, we identified statistically significant interactions between regular aspirin/NSAID use and variants in 6q24.1 (top hit rs72833769), which has evidence of influencing expression of TBC1D7 (a subunit of the TSC1-TSC2 complex, a key regulator of MTOR activity), and variants in 5p13.1 (top hit rs350047), which is associated with expression of PTGER4 (codes a cell surface receptor directly involved in the mode of action of aspirin). Genetic variants with functional impact may modulate the chemopreventive effect of regular aspirin use, and our study identifies putative previously unidentified targets for additional mechanistic interrogation.
Matèries
Matèries (anglès)
Citació
Citació
DREW, David a., KIM, Andre e., LIN, Yi, QU, Conghui, MORRISON, John, LEWINGER, Juan pablo, KAWAGUCHI, Eric, WANG, Jun, FU, Yubo, ZEMLIANSKAIA, Natalia, DÍEZ OBRERO, Virginia, BIEN, Stephanie a., DIMOU, Niki, ALBANES, Demetrius, BAURLEY, James w., WU, Anna h., BUCHANAN, Daniel d., POTTER, John d., PRENTICE, Ross l., HARLID, Sophia, ARNDT, Volker, BARRY, Elizabeth l., BERNDT, Sonja i., BOURAS, Emmanouil, BRENNER, Hermann, BUDIARTO, Arif, BURNETT HARTMAN, Andrea, CAMPBELL, Peter t., CARRERAS TORRES, Robert, CASEY, Graham, CHANG CLAUDE, Jenny, CONTI, David v., DEVALL, Matthew a. m., FIGUEIREDO, Jane c., GRUBER, Stephen b., GSUR, Andrea, GUNTER, Marc j., HARRISON, Tabitha a., HIDAKA, Akihisa, HOFFMEISTER, Michael, HUYGHE, Jeroen r., JENKINS, Mark a., JORDAHL, Kristina m., KUNDAJE, Anshul, LE MARCHAND, Loic, LI, Li, LYNCH, Brigid m., MURPHY, Neil, NASSIR, Rami, NEWCOMB, Polly a., NEWTON, Christina c., OBÓN SANTACANA, Mireia, OGINO, Shuji, OSE, Jennifer, PAI, Rish k., PALMER, Julie r., PAPADIMITRIOU, Nikos, PARDAMEAN, Bens, PELLATT, Andrew j., PEOPLES, Anita r., PLATZ, Elizabeth a., RENNERT, Gad, RUIZ NARVAEZ, Edward, SAKODA, Lori c., SCACHERI, Peter c., SCHMIT, Stephanie l., SCHOEN, Robert e., STERN, Mariana c., SU, Yu-ru, THOMAS, Duncan c., TIAN, Yu, TSILIDIS, Konstantinos k., ULRICH, Cornelia m., UM, Caroline y., VAN DUIJNHOVEN, Fränzel j. b., VAN GUELPEN, Bethany, WHITE, Emily, HSU, Li, MORENO AGUADO, Víctor, PETERS, Ulrike, CHAN, Andrew t., GAUDERMAN, W. james. Two genome-wide interaction loci modify the association of nonsteroidal anti-inflammatory drugs with colorectal cancer. _Science Advances_. 2024. Vol. 10, núm. 22. [consulta: 25 de gener de 2026]. ISSN: 2375-2548. [Disponible a: https://hdl.handle.net/2445/214828]